Sunday, May 25th
Last update09:57:45 PM GMT
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
To accomplish its mission of increasing the health security of the U.S., the Centers for Disease... |
The Food and Drug Administration (FDA) announced on Tuesday that it will limit access to seasonal... | ||
|
 Wait, aren't "clean" rooms supposed to be, well, "clean" of germs and other pesky microscopic particles?
Maybe... |
